Fingerprint
Dive into the research topics of 'Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically